Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
The company primarily provides end-to-end solutions for product development and manufacturing as well as research and development (R&D) of formulations, preparation and submission of regulatory dossiers in the Indian and global markets and other testing services. The company is also engaged in the manufacture and sale of branded drugs and active pharmaceutical ingredients (APIs).
As a CDMO, the company manufactures a wide range of dosage forms including tablets, capsules, liquid medicines, vials, ampoules, blow-filled closures, topical preparations, eye drops, dry powder injections and gummy bears, to name a few.
The company has produced a total of 4,025 commercialized formulations in over 60 dosage forms. In the financial year 2023, the company manufactured formulations for 26 of the top 30 pharmaceutical companies in India in terms of revenue. For its CDMO business, the company operates 10 manufacturing units with a cumulative production capacity of 49.21 billion units annually (as of September 30, 2023).
The company plans to expand its production capacity with two additional production units for its CDMO business to be commissioned in FY 2025. Some of its production facilities have been accredited by various global regulatory bodies such as the European Good Manufacturing Practice (EU-GMP), the World Health Organization Good Manufacturing Practice (WHO-GMP) and the United States National Sanitation Foundation (US NSF).
As of September 30, 2023, Akums Drugs and Pharmaceuticals had a total of 16,463 employees, including 7,211 full-time employees and 9,252 contract employees.
Akums Drugs and Pharmaceuticals IPO – Details
| IPO Opening Date | 30 July 2024 |
| IPO Closing Date | 01 August 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: 2,73,45,162 Shares Worth ₹1,856.74 Crore Fresh Issue: 1,00,14,727 Shares Worth ₹680.00 Crore Offer For Sale: 1,73,30,435 Shares Worth ₹1,176.74 Crore |
| Face Value | ₹2 per equity share |
| IPO Price | ₹646 – ₹679 per share |
| Market Lot | 22 Shares |
| Min Order | 22 Shares ( 1 Lot ) |
| Employee Discount | Rs 64 |
| Listing At | BSE, NSE |
| Register | Link Intime India Private Ltd |
| QIB Shares Offered | 75% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 10% |
Akums Drugs and Pharmaceuticals IPO – Date Schedule
| IPO Open Date | 30 July 2024 |
| IPO Close Date | 01 August 2024 |
| Basis of Allotment | 02 August 2024 |
| Initiation of Refund | 05 August 2024 |
| Credit of Shares to Demat Account | 05 August 2024 |
| IPO Listing Date | 06 August 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on August 01, 2024 |
Akums Drugs and Pharmaceuticals IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 22 | ₹14,938 |
| Retail (Max) | 13 | 286 | ₹1,94,194 |
| S-HNI (Min) | 14 | 308 | ₹2,09,132 |
| S-HNI (Max) | 66 | 1452 | ₹9,85,908 |
| B-HNI (Min) | 67 | 1474 | ₹10,00,846 |
Competitive Strengths
- Largest India-focused CDMO serving the Indian domestic pharmaceutical industry (Source: F&S Report);
- Diverse client base with longstanding CDMO relationships;
- Large and rapidly growing R&D capabilities across its product portfolio;
- Strategic presence across the pharmaceutical value chain; and
- Experienced and entrepreneurial management team with a proven track record and marquee healthcare focused PE investor.
Company Promoters
- Sanjeev Jain
- Sandeep Jain
- Akums Master Trust
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2022 | 3694.52 | 3874.94 | -250.87 | 357.95 |
| 31 March 2023 | 3700.92 | 3475.92 | 97.81 | 536.97 |
| 31 March 2024 | 4212.20 | 4231.45 | 0.79 | 491.56 |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 0.11% |
| ROCE | 3.37% |
| Debt/Equity | 0.69 |
| RoNW | -0.57 |
| P/BV | 13.69 |
| PAT Margin (%) | 0.02 |
Object Of The Issue
- Repayment/ prepayment of indebtedness of the company and its Subsidiaries;
- Funding incremental working capital requirements of the company;
- Pursuing inorganic growth initiatives through acquisitions; and
- General corporate purposes.
Akums Drugs and Pharmaceuticals IPO Peer Comparison
| S. No. | Face Value | Company Name | PE |
| 1 | 2 | Divi’s Laboratories | 74.99 |
| 2 | 1 | Suven Pharma | 69.54 |
| 3 | 1 | Gland Pharma | 42.45 |
| 4 | 5 | Torrent Pharma | 60.20 |
| 5 | 2 | Alkem Laboratories | 34.18 |
| 6 | 1 | Eris Lifesciences | 34.95 |
| 7 | 1 | JB Chemicals | 51.38 |
| 8 | 1 | Mankind Pharma | 44.65 |
| 9 | 10 | Innova Captab | 29.91 |
Akums Drugs and Pharmaceuticals IPO Promoter Holding
| Pre Issue Share Holding | 82.44% |
| Post Issue Share Holding | 66.18% |
Akums Drugs and Pharmaceuticals IPO Prospectus
Company Contact Information
| Akums Drugs and Pharmaceuticals Limited 304, Mohan Place, LSC Saraswati Vihar, Delhi – 110 034 Phone: +91 11 6904 1000 Email: cs@akums.net Website: http://www.akums.in/ |
Akums Drugs and Pharmaceuticals IPO Registrar
| Link Intime India Private Ltd Phone: +91-22-4918 6270 Email: akumsdrugs.ipo@linkintime.co.in Website: https://linkintime.co.in/initial_offer/public-issues.html |
Akums Drugs and Pharmaceuticals IPO Lead Manager(s)
| 1. ICICI Securities Limited 2. Axis Capital Limited 3. Ambit Private Limited 4. Citigroup Global Markets India Private Limited |
Akums Drugs and Pharmaceuticals IPO FAQs
| What is Akums Drugs and Pharmaceuticals IPO? Akums Drugs and Pharmaceuticals IPO is a main-board IPO. The issue is priced at ₹646 to ₹679 per equity share. The IPO is to be listed on BSE & NSE. |
| When Akums Drugs and Pharmaceuticals IPO will open? The IPO is to open on 30 July 2024 for QIB, NII, and Retail Investors. |
| What is Akums Drugs and Pharmaceuticals IPO Investors Portion? The investors’ portion for QIB – 75%, NII – 15%, and Retail – 10%. |
| How to Apply the Akums Drugs and Pharmaceuticals IPO? You can apply Akums Drugs and Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Akums Drugs and Pharmaceuticals IPO through Angle One? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One. |
| How to Apply the Akums Drugs and Pharmaceuticals IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Akums Drugs and Pharmaceuticals IPO through Upstox? Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox. |
| How to Apply the Akums Drugs and Pharmaceuticals IPO through IIFL? Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL. |
| What is Akums Drugs and Pharmaceuticals IPO Size? Akums Drugs and Pharmaceuticals IPO size is ₹1,856.74 Crore. |
| What is Akums Drugs and Pharmaceuticals IPO Price Band? Akums Drugs and Pharmaceuticals IPO Price Band is ₹646 to ₹679. |
| What is Akums Drugs and Pharmaceuticals IPO Minimum and Maximum Lot Size for retail? The minimum bid is 22 Shares with ₹14,938 amount while the maximum bid is 286 Shares with ₹1,94,194. |
| What is the Akums Drugs and Pharmaceuticals IPO Allotment Date? Akums Drugs and Pharmaceuticals IPO allotment date is 02 August 2024. |
| What is the Akums Drugs and Pharmaceuticals IPO Listing Date? Akums Drugs and Pharmaceuticals IPO listing date is 06 August 2024. The IPO is to be listed on BSE and NSE. |
